| |
| |
|
| Insider
Information: |
Best Lawrence C |
| Relationship: |
Director |
| City: |
Braintree |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
4 |
|
| Direct
Shares |
385,780 |
|
|
Indirect Shares
|
8,680 |
|
|
| Direct
Value |
$27,085,556 |
|
|
|
Indirect Value
|
$654,125 |
|
|
| Total
Shares |
394,460 |
|
|
| Total
Value |
$27,739,681 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Boston Scientific Corp |
BSX |
EVP |
2007-07-06 |
309,389 |
2007-07-06 |
8,680 |
Premium* |
|
|
Haemonetics Corp |
HAE |
Director |
2014-06-12 |
10,001 |
2006-06-16 |
0 |
Premium* |
|
|
Biogen Idec Inc |
BIIB |
Director |
2008-06-19 |
5,600 |
2007-05-25 |
0 |
Premium* |
|
|
Myriad Genetics Inc |
MYGN |
Director |
2019-12-05 |
60,790 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
108 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 5
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| MYGN |
Myriad Genetics Inc |
Director |
– • – |
2009-09-16 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
190,000 |
|
- |
|
| BSX |
Boston Scientific Corp |
SVP and CFO |
• – – |
2004-04-05 |
4 |
OE |
$0.00 |
$0 |
D/D |
325,000 |
355,438 |
|
- |
|
| BSX |
Boston Scientific Corp |
SVP and CFO |
• – – |
2004-04-06 |
4 |
OE |
$0.00 |
$0 |
D/D |
325,000 |
355,438 |
|
- |
|
| BSX |
Boston Scientific Corp |
SVP and CFO |
• – – |
2004-04-07 |
4 |
OE |
$0.00 |
$0 |
D/D |
325,000 |
355,438 |
|
- |
|
| BIIB |
Biogen Idec Inc |
Director |
– • – |
2007-05-25 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,250 |
1,250 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Director |
– • – |
2007-05-31 |
4 |
A |
$0.00 |
$0 |
D/D |
2,300 |
3,550 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
EVP |
• – – |
2007-07-01 |
4/A |
D |
$0.00 |
$0 |
D/D |
(0) |
242,189 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
EVP |
• – – |
2007-07-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
10,000 |
242,189 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
EVP |
• – – |
2007-07-06 |
4/A |
D |
$0.00 |
$0 |
D/D |
(0) |
309,389 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
EVP |
• – – |
2007-07-06 |
4 |
OE |
$0.00 |
$0 |
D/D |
67,200 |
305,214 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Director |
– • – |
2008-06-19 |
4 |
A |
$0.00 |
$0 |
D/D |
2,050 |
5,600 |
0 |
- |
|
| HAE |
Haemonetics Corp |
Director |
– • – |
2013-07-24 |
4 |
A |
$0.00 |
$0 |
D/D |
1,649 |
10,001 |
0 |
- |
|
| MYGN |
Myriad Genetics Inc |
Director |
– • – |
2014-12-04 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
10,000 |
0 |
- |
|
| MYGN |
Myriad Genetics Inc |
Director |
– • – |
2015-12-03 |
4 |
A |
$0.00 |
$0 |
D/D |
7,500 |
17,500 |
0 |
- |
|
| MYGN |
Myriad Genetics Inc |
Director |
– • – |
2016-12-01 |
4 |
A |
$0.00 |
$0 |
D/D |
15,024 |
32,524 |
0 |
- |
|
| MYGN |
Myriad Genetics Inc |
Director |
– • – |
2017-11-30 |
4 |
A |
$0.00 |
$0 |
D/D |
7,219 |
39,743 |
0 |
- |
|
| MYGN |
Myriad Genetics Inc |
Director |
– • – |
2018-11-29 |
4 |
A |
$0.00 |
$0 |
D/D |
9,360 |
49,103 |
0 |
- |
|
| MYGN |
Myriad Genetics Inc |
Director |
– • – |
2019-12-05 |
4 |
A |
$0.00 |
$0 |
D/D |
11,687 |
60,790 |
0 |
- |
|
| HAE |
Haemonetics Corp |
Director |
– • – |
2007-08-01 |
4 |
A |
$0.01 |
$3 |
D/D |
287 |
100,287 |
0 |
- |
|
| HAE |
Haemonetics Corp |
Director |
– • – |
2008-07-31 |
4 |
A |
$0.01 |
$4 |
D/D |
354 |
100,641 |
0 |
- |
|
| HAE |
Haemonetics Corp |
Director |
– • – |
2009-07-30 |
4 |
A |
$0.01 |
$4 |
D/D |
367 |
101,008 |
0 |
- |
|
| HAE |
Haemonetics Corp |
Director |
– • – |
2011-07-21 |
4 |
A |
$0.01 |
$9 |
D/D |
944 |
3,145 |
0 |
- |
|
| HAE |
Haemonetics Corp |
Director |
– • – |
2012-07-27 |
4 |
A |
$0.01 |
$10 |
D/D |
1,031 |
4,176 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
officerTitle |
• – – |
2003-09-11 |
4 |
OE |
$5.19 |
$5,203,727 |
D/D |
1,003,128 |
1,015,594 |
|
- |
|
| BSX |
Boston Scientific Corp |
SVP and CFO |
• – – |
2004-03-05 |
4 |
OE |
$6.13 |
$1,378,125 |
D/D |
225,000 |
255,438 |
|
- |
|
108 Records found
|
|
Page 1 of 5 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
